The role
As a member of our Applications Development team, you will work on creating and optimizing applications for our proprietary analytical platform, Amperia. In this role, you’ll collaborate with a diverse group of chemists, biotechnologists, physicists, and engineers to develop innovative solutions that advance protein analysis. This is a unique opportunity to be part of groundbreaking work in a collaborative, multidisciplinary environment. The position is based in Cambridge, UK.
Your responsibilities
- Develop and optimise assays and applications based on Amperia
- Plan activities guided by senior scientists, and execute independently
- Work together with the Science team to troubleshoot complex problems
- Carry out manufacturing procedures of explorative runs of new biosensors and reagents
- Analyse data independently, write experimental reports and communicate results
Minimum requirements
- MSc in Biochemistry or related field
- Lab experience and handling of protein samples
- Experience with one or more of the following: ELISA, SPR, BLI, or other binding assays
- Competent user of Microsoft Office
- Basic knowledge of Matlab or Python is a plus
What we offer
- Dynamic and fast-paced work environment
- Be part of a step-change in life science tools
- Working on a cutting‑edge technology at the intersection of biology, engineering, and data science
- Salary: 35000£ - 39000£ depending on experience
- Most important of all, join a great team!
Start date
August 2026 or by arrangement
Primary location
Cambridge, UK
Research Associate Cambridge employer: Meeveem Limited
Meeveem Limited is an exceptional employer that values its employees by fostering a collaborative and innovative work culture in the heart of Yorkshire. With a strong focus on professional development, employees are encouraged to grow their skills and advance their careers while enjoying competitive benefits and a supportive environment that prioritises work-life balance. Joining Meeveem means being part of a dynamic team dedicated to making a meaningful impact in the cardiovascular and endovascular sectors.
